Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Neoplasms 5Venous Thrombosis 4Venous Thromboembolism 2Pulmonary Embolism 2Thrombosis 1Thromboembolism 1Myeloproliferative Disorders 1

Interventions

apixaban 11Dalteparin 10Rivaroxaban 7Enoxaparin 5Fondaparinux 4Tinzaparin 3Heparin, Low-Molecular-Weight 3Aspirin 3edoxaban 2Warfarin 2Observation 2Dabigatran 2sotorasib 1calcium heparin 1betrixaban 1bemiparin 1argatroban 1Tacrolimus 1Tablets 1Simvastatin 1Rosuvastatin Calcium 1Nadroparin 1Heparin 1Gemcitabine 1Drug Therapy 1Data Collection 1Cyclosporine 1AVE 5026 1ALT-836 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Venous Thromboembolism × edoxaban × Clear all
NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT02073682 2019-03-06

Cancer Venous Thromboembolism (VTE)

Daiichi Sankyo

Phase 3 Completed
1,046 enrolled 24 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡